Back to Journals » Neuropsychiatric Disease and Treatment » Volume 7 » Issue 1

A biological pathway linking inflammation and depression: activation of indoleamine 2,3-dioxygenase

Authors Christmas D, Potokar J, Davies

Published 13 July 2011 Volume 2011:7(1) Pages 431—439

DOI https://doi.org/10.2147/NDT.S17573

Review by Single-blind

Peer reviewer comments 4


David M Christmas, JP Potokar, Simon JC Davies
Academic Unit of Psychiatry, School of Social and Community Medicine, University of Bristol, Bristol, UK
A presentation relating to this manuscript was made by Dr David Christmas at the 9th International Meeting on Clinical Pharmacology in Psychiatry (9th IMCPP) in Copenhagen, Denmark in September 2010

Abstract: This article highlights the evidence linking depression to increased inflammatory drive and explores putative mechanisms for the association by reviewing both preclinical and clinical literature. The enzyme indoleamine 2,3-dioxygenase is induced by proinflammatory cytokines and may form a link between immune functioning and altered neurotransmission, which results in depression. Increased indoleamine 2,3-dioxygenase activity may cause both tryptophan depletion and increased neurotoxic metabolites of the kynurenine pathway, two alterations which have been hypothesized to cause depression. The tryptophan-kynurenine pathway is comprehensively described with a focus on the evidence linking metabolite alterations to depression. The use of immune-activated groups at high risk of depression have been used to explore these hypotheses; we focus on the studies involving chronic hepatitis C patients receiving interferon-alpha, an immune activating cytokine. Findings from this work have led to novel strategies for the future development of antidepressants including inhibition of indoleamine 2,3-dioxygenase, moderating the cytokines which activate it, or addressing other targets in the kynurenine pathway.

Keywords:
depression, inflammation, indoleamine 2,3-dioxygenase, kynurenine, serotonin, tryptophan

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]